Neuraxis, Inc. (NRXS) - Form 8-K Summary
Business Context and Reporting Period
Neuraxis, Inc., a Delaware corporation listed on NYSE American under the symbol NRXS, filed this Current Report on Form 8-K on November 12, 2024. The filing serves to announce the Company's financial results for the third quarter ended September 30, 2024. The Company is designated as an emerging growth company.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that these results have been announced and refers investors to the press release furnished as Exhibit 99.1 for detailed financial data.
Material Changes
No specific material changes versus the prior comparable period are detailed in the text of this Form 8-K. The filing indicates that the Company has released its Q3 2024 results, but the specific variances and performance metrics are contained within the referenced Exhibit 99.1.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other registration statements, except as expressly set forth. No specific guidance, outlook, management commentary, or risk factors are detailed in the body of this 8-K text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 12, 2024) for actual Q3 2024 revenue, net income, and cash flow figures.
- Verify the Company's liquidity position and debt obligations as detailed in the full press release.
- Check for any forward-looking statements or updated guidance provided in the referenced press release.
- Confirm the status of the Company as an emerging growth company and any related accounting election impacts.